Genetic Begin Period Cash Flow from 2010 to 2024

Stocks . Australia . 
Stock . Genetic Technologies
GTG Stock   0.04  0.00  0.00%   
Genetic Technologies Begin Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. Begin Period Cash Flow is likely to outpace its year average in 2024. Begin Period Cash Flow is the amount of cash Genetic Technologies has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2012-03-31
Previous Quarter
1.2 M
Current Value
3.7 M
Quarterly Volatility
6.1 M
 
Yuan Drop
 
Covid
Check Genetic Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genetic Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 508.1 K, Interest Expense of 83.6 K or Total Revenue of 5.3 M, as well as many indicators such as . Genetic financial statements analysis is a perfect complement when working with Genetic Technologies Valuation or Volatility modules.
  
This module can also supplement various Genetic Technologies Technical models . Check out the analysis of Genetic Technologies Correlation against competitors.
For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Genetic Stock Analysis

When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY